Roche News

Main menu
Contents

Want to see the real deal?
More inside scoop? View in App

My Company

#Polls

Browse by:

Companies

Keywords

Customize Interests

Blog

COMPANY

SUPPORT

Rooftop Slushie Get Referrals to FAANG

DOWNLOAD THE APP:

Roche

3.9 (46 reviews)

REVIEW THIS COMPANY

Roche The Athletic / May 1, 2022

Cycling hero Stephen Roche has been ordered to repay €750,000 after a Spanish court found he negligently bankrupted his Marbella firm.

https://extra.ie/2022/05/01/news/irish-news/stephen-roche-fraud

Cycling hero Stephen Roche found guilty of fraud by Spanish court

The Athletic

Roche The Athletic / May 1, 2022

Larry Roche, who died last Sunday in St Vincent’s Hospital following a month of illness, is renowned as the father of champion cyclist Stephen, but there is more to his story than that magical year of 1987 when Stephen ruled the world of cycling.

https://www.independent.ie/irish-news/obituary-larry-roche-whose-passion-for-cycling-led-to-his-son-stephens-victory-in-the-1987-tour-de-france-41603751.html

Obituary: Larry Roche, whose passion for cycling led to his son Stephen's victory in the 1987 Tour de France

The Athletic

Roche The Athletic / May 1, 2022

Chew over the teamsheet, then discuss overall and individual performances and what the result today means for the club’s top-four hopes

https://theathletic.com/3278097/2022/04/30/arsenal-score-west-ham-gunners-afc/

Arsenal fans: Discuss the West Ham game with our writer Art de Roche

The Athletic

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The HPV Testing Market research report offers compre

https://www.riponcollegedays.com/hpv-testing-market-size-outlook-and-forecast/

HPV Testing Market Size, Outlook And Forecast | Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc. – Ripon College Days

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The Blood Glucose Test Strips Market research report

https://www.riponcollegedays.com/blood-glucose-test-strips-market-size-outlook-and-forecast/

Blood Glucose Test Strips Market Size, Outlook And Forecast | Roche, Lifescan, Bayer, Abbott, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, Nipro Dagnostics – Ripon College Days

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The Anti-tumor Drug Market research report offers co

https://www.riponcollegedays.com/anti-tumor-drug-market-size-outlook-and-forecast/

Anti-tumor Drug Market Size, Outlook And Forecast | Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca – Ripon College Days

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The Real-Time PCR Machines Market research report of

https://www.riponcollegedays.com/real-time-pcr-machines-market-size-outlook-and-forecast/

Real-Time PCR Machines Market Size, Outlook And Forecast | Roche, Thermo Fisher, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne – Ripon College Days

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The Digital Pathology Market research report offers

https://www.riponcollegedays.com/digital-pathology-market-size-outlook-and-forecast/

Digital Pathology Market Size, Outlook And Forecast | Danaher, Hamamatsu Photonics, Roche, Philips, Olympus, PerkinElmer, Sectra, Nikon, Definiens, 3DHISTECH – Ripon College Days

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New Jersey, United States - The latest research report provides a complete assessment of the CXCR4 A

https://www.themobility.club/news/2022/04/30/cxcr4-antagonists-market-size-trends-and-forecast-to-2029/

CXCR4 Antagonists Market Size, Trends and Forecast to 2029 | Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics, Harmonic Pharma and Upsher-Smith Laboratories. – themobility.club

Center For Biosimilars

Roche Center For Biosimilars / Apr 30, 2022

New information on oncology biosimilars have sprouted during the month of April, including an FDA approval, study results from conferences, and data on pegfilgrastim biosimilar utilization and spending.

https://www.centerforbiosimilars.com/view/biosimilar-oncology-roundup-april-2022